Celon Pharma S.A. (WSE:CLN)
Poland flag Poland · Delayed Price · Currency is PLN
21.35
-0.10 (-0.47%)
At close: Dec 5, 2025

Celon Pharma Revenue

Celon Pharma had revenue of 71.13M PLN in the quarter ending September 30, 2025, with 39.34% growth. This brings the company's revenue in the last twelve months to 225.60M, up 7.29% year-over-year. In the year 2024, Celon Pharma had annual revenue of 205.55M, down -4.25%.

Revenue (ttm)
225.60M
Revenue Growth
+7.29%
P/S Ratio
5.10
Revenue / Employee
398.58K
Employees
558
Market Cap
1.15B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024205.55M-9.12M-4.25%
Dec 31, 2023214.66M20.78M10.72%
Dec 31, 2022193.89M-2.20M-1.12%
Dec 31, 2021196.09M38.64M24.54%
Dec 31, 2020157.45M55.20M53.99%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
NEUCA13.34B
Diagnostyka2.30B
Centrum Medyczne ENEL-MED820.59M
Synektik Spólka Akcyjna623.20M
Mercator Medical585.57M
Voxel568.83M
Selvita373.90M
Ryvu Therapeutics90.41M
Revenue Rankings